Jobs Data, Treatment Buzz Keep Stock Gains in Check

Tensions surrounding Gilead Sciences weighed on the market

Deputy Editor
Apr 23, 2020 at 4:38 PM
facebook X logo linkedin

The Dow scraped together a 40-point win, as earlier gains were slashed after documents were published on Gilead Science's (GILD) potential coronavirus treatment remdesivir, which drew disappointing results. However, Gilead claims the results of the drug's trial remain "inconclusive." The S&P 500 and Nasdaq slipped below breakeven in the final minutes of trading, as all three indexes had gains pared by this morning's dismal jobs report, which showed that the total number of Americans who have filed for unemployment is now over 26 million.

Continue reading for more on today's market, including:

  • Investors eye mining stock after choppy week for commodities. 
  • Why this blue-chip stock dropped before earnings.
  • Plus, TSN fights mounting pressure; Hershey stock melts after quarterly report, and Gap shares grim outlook.  

The Dow Jones Industrial Average (DJI - 23,515.26) rose 39.4 points, or 0.2% for the day. Exxon Mobil (XOM) topped the charts with a 3.1% win, while McDonald's (MCD) finished at the bottom with a 2.3% loss.

The S&P 500 Index (SPX - 2,797.80) lost 1.5 points, or 0.05%, while the Nasdaq Composite (IXIC - 8,494.75) shed 0.6 point, or 0.01%, for the day.

The Cboe Volatility Index (VIX - 41.38) fell 0.6 point, or 1.4%. 

Closing Index Summary April 23

NYSE and Nasdaq Stats April 23

5 Items on Our Radar Today

  1. New-home sales in the U.S. dropped 15.4% in March, the largest decline since July 2013, to an annualized 670,000 pace. Other housing market figures are also showing effects of the pandemic. (Bloomberg)
  2. Georgia reports a higher death toll the eve before businesses are set to reopen per Governor Brian Kemp's announcement earlier in the week. (The Washington Post)
  3. Tyson stock brushes off plan closures. 
  4. Hershey Food's international sales sport bad news.
  5. GPS isn't too far from its all-time low.

Earnings April 23

Unusual Options Activity April 23

Data courtesy of Trade-Alert

Oil Climbs Nearly 20% 

Oil futures rose for the second straight session as tensions between the U.S. and Iran began to reignite. June-dated crude climbed $2.72, or 19.7%, to settle at $16.50 a barrel. 

Gold futures also climbed for a second straight session, as unemployment rates continued to rise. Gold for June delivery rose $7.10, 0.4%, to settle at $1,745.40 per ounce.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI